Island Pharmaceuticals Ltd
ILA•Health Care•Biotechnology•Last updated: Dec 25
About
Island Pharmaceuticals Ltd is a drug development company focused on the repurposing of existing drugs for the prevention and treatment of mosquito-borne viral diseases. The company is primarily engaged in the development of its lead asset, ISLA-101, which is aimed at preventing dengue fever and other mosquito-borne illnesses. Island Pharmaceuticals leverages its expertise in drug repurposing to accelerate the development timeline and reduce costs associated with bringing new therapies to market.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- ILA
Related Shares
Investor Resources
Should you buy Island Pharmaceuticals Ltd right now?
While ILA looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now